Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for AC Immune (ACIU) over the last 10 years, with Q2 2025 value amounting to $33820.9.

  • AC Immune's Other Operating Expenses fell 2540.19% to $33820.9 in Q2 2025 from the same period last year, while for Sep 2025 it was $48690.0, marking a year-over-year decrease of 9107.24%. This contributed to the annual value of $162096.1 for FY2024, which is 9032.41% down from last year.
  • Per AC Immune's latest filing, its Other Operating Expenses stood at $33820.9 for Q2 2025, which was down 2540.19% from -$1112.3 recorded in Q1 2025.
  • AC Immune's 5-year Other Operating Expenses high stood at $497009.1 for Q1 2022, and its period low was -$1112.3 during Q1 2025.
  • In the last 5 years, AC Immune's Other Operating Expenses had a median value of $276595.7 in 2021 and averaged $252158.5.
  • As far as peak fluctuations go, AC Immune's Other Operating Expenses soared by 24235.14% in 2021, and later plummeted by 10142.77% in 2025.
  • Quarter analysis of 5 years shows AC Immune's Other Operating Expenses stood at $275463.5 in 2021, then soared by 50.35% to $414170.7 in 2022, then decreased by 3.37% to $400210.9 in 2023, then crashed by 96.01% to $15981.3 in 2024, then surged by 111.63% to $33820.9 in 2025.
  • Its Other Operating Expenses was $33820.9 in Q2 2025, compared to -$1112.3 in Q1 2025 and $15981.3 in Q4 2024.